Aβ1–42 induced ERS and impaired insulin signaling.
ERS inhibition alleviated the IRS-1 serine phosphorylation.
JNK inhibition attenuated the IRS-1 serine phosphorylation.
ERS might contribute to insulin signaling impairment via JNK activation.
ERS/JNK/IRS-1 pathway might contribute to Aβ1–42-induced Tau hyperphosphorylation.